99 related articles for article (PubMed ID: 20119931)
1. Challenge of phosphorus control in hemodialysis patients: a problem of adherence?
Arenas MD; Malek T; Gil MT; Moledous A; Alvarez-Ude F; Reig-Ferrer A
J Nephrol; 2010; 23(5):525-34. PubMed ID: 20119931
[TBL] [Abstract][Full Text] [Related]
2. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
Mahdavi-Mazdeh M; Zamyadi M; Norouzi S; Heidary Rouchi A
Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
[TBL] [Abstract][Full Text] [Related]
3. Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia.
Nerbass FB; Morais JG; dos Santos RG; Krüger TS; Koene TT; da Luz Filho HA
J Bras Nefrol; 2010; 32(2):149-55. PubMed ID: 21103674
[TBL] [Abstract][Full Text] [Related]
4. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
Dolores Arenas M; Pérez-García R; Bennouna M; Blanco A; Mauricio O; Prados MD; Lerma JL; Luisa Muñiz M; Belén Martín M;
Nefrologia; 2013; 33(2):196-203. PubMed ID: 23364580
[TBL] [Abstract][Full Text] [Related]
5. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D
J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741
[TBL] [Abstract][Full Text] [Related]
6. [Adherence to therapy in patients on hemodialysis].
Gerbino G; Dimonte V; Albasi C; Lasorsa C; Vitale C; Marangella M
G Ital Nefrol; 2011; 28(4):416-24. PubMed ID: 21809311
[TBL] [Abstract][Full Text] [Related]
7. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
8. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
Cupisti A; D'Alessandro C; Baldi R; Barsotti G
J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
[TBL] [Abstract][Full Text] [Related]
9. Dialysis staff encouragement and fluid control adherence in patients on hemodialysis.
Yokoyama Y; Suzukamo Y; Hotta O; Yamazaki S; Kawaguchi T; Hasegawa T; Chiba S; Moriya T; Abe E; Sasaki S; Haga M; Fukuhara S
Nephrol Nurs J; 2009; 36(3):289-97. PubMed ID: 19588696
[TBL] [Abstract][Full Text] [Related]
10. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
11. Patient-Reported Factors Associated With Poor Phosphorus Control in a Maintenance Hemodialysis Population.
Joson CG; Henry SL; Kim S; Cheung MY; Parab P; Abcar AC; Jacobsen SJ; Morisky DE; Sim JJ
J Ren Nutr; 2016 May; 26(3):141-8. PubMed ID: 26614738
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Dietary adherence in Hispanic patients receiving hemodialysis.
Morales López C; Burrowes JD; Gizis F; Brommage D
J Ren Nutr; 2007 Mar; 17(2):138-47. PubMed ID: 17321954
[TBL] [Abstract][Full Text] [Related]
14. Illness representations are associated with fluid nonadherence among hemodialysis patients.
Chilcot J; Wellsted D; Farrington K
J Psychosom Res; 2010 Feb; 68(2):203-12. PubMed ID: 20105704
[TBL] [Abstract][Full Text] [Related]
15. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
Ibrahim S
Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
[TBL] [Abstract][Full Text] [Related]
16. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.
Ring T; Nielsen C; Andersen SP; Behrens JK; Sodemann B; Kornerup HJ
Nephrol Dial Transplant; 1993; 8(4):341-6. PubMed ID: 8390009
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
[TBL] [Abstract][Full Text] [Related]
18. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
[TBL] [Abstract][Full Text] [Related]
19. Use of calcium carbonate as a phosphate binder in dialysis patients.
Hercz G; Kraut JA; Andress DA; Howard N; Roberts C; Shinaberger JH; Sherrard DJ; Coburn JW
Miner Electrolyte Metab; 1986; 12(5-6):314-9. PubMed ID: 3807829
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and causes of cough in chronic dialysis patients: a comparison between hemodialysis and peritoneal dialysis patients.
Min F; Tarlo SM; Bargman J; Poonai N; Richardson R; Oreopoulos D
Adv Perit Dial; 2000; 16():129-33. PubMed ID: 11045277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
